私募超44000次调研 去了哪些行业?
Zhong Guo Ji Jin Bao·2025-11-30 15:14

Core Insights - Private equity firms have conducted over 44,000 research activities on A-share listed companies this year, with a focus on hard technology sectors such as electronics, biomedicine, and machinery [1][3] - Future investment focus will be on artificial intelligence, innovative pharmaceuticals, new consumption trends, and structural opportunities arising from "anti-involution" policies [2][6] Group 1: Research Activity Overview - A total of 2,579 private equity firms have participated in A-share research activities, covering 2,184 stocks across 30 primary industries, with a total of 44,702 research instances [3] - The top three industries by research frequency are electronics (8,732 times), biomedicine (6,341 times), and machinery (5,437 times) [3] - Notable stocks in the electronics sector include Luxshare Precision, which was researched 335 times, followed by Langchao Technology and Crystal Optoelectronics [3][4] Group 2: Key Private Equity Firms - Zhengyuan Investment has been the most active, conducting 1,002 research activities this year [3] - Other significant firms include Panjing Investment, Gao Yi Asset, and Danshui Spring, with research activities of 429, 389, and 319 times respectively [3][4] - Panjing Investment has shown particular interest in stocks with three or more research instances, including Luxshare Precision and Jiangbolong [4] Group 3: Sector Insights - The electronics industry is leading due to accelerated domestic substitution in semiconductors and the initiation of a consumer electronics innovation cycle [5] - The biomedicine sector is favored for its diverse stock options and the acceleration of innovative drug approvals, alongside a recovery in medical consumption [5] - The power equipment sector benefits from the continuous growth in new energy installations, attracting significant research interest from private equity firms [5] Group 4: Market Trends and Future Outlook - The market is transitioning from valuation-driven to earnings-driven, with a focus on high-growth sectors such as AI, innovative pharmaceuticals, and machinery [6][7] - Investment strategies are being adjusted to optimize portfolios in high-prosperity industries while preparing for potential style shifts [7] - There is an increasing emphasis on individual stock performance, with a focus on sectors that show structural growth potential without relying on overall economic recovery [7]